Treatment CAS 40077-57-4 Aviptadil Acetate VIP Aviptadil

• Customization: Available
• Powder: Yes
• Customized: Negotiable
• Model NO.: QS-Aviptadil Acetate
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Aviptadil Acetate
• Name: Aviptadil Acetate Powder
• Appearance: White Powder
• Colour: White
• Grade: Pharmaceutical Grade
• Assay: >99%
• Application: API
• Specific: COA
• Test Method: HPLC
• Mf: C147h238n44o42s
• MW: 3325.8
• CAS: 40077-57-4
• Density: 1.47 ± 0.1 Gcm3 (Predicted)
• Refractive Index: 1.659 (Predicted)
• Logp: -4.26 (Predicted)
• Transport Package: Negotiable
• Specification: >99%
• Trademark: QS-Aviptadil Acetate
• Origin: Xian
• Production Capacity: 500kg/Month

Product Description

Treatment CAS 40077-57-4 Aviptadil Acetate Vip Aviptadil

Product Description

Product Details

Product Name	Aviptadil acetate
Appearance	White Powder
Assay	99%
MW	3325.8
MF	C147H238N44O42S

Aviptadil acetate is a peptide drug mainly composed of 28 amino acids, which has vasodilation and blood pressure lowering effects.
Aviptadil acetate is a linear peptide extracted from the small intestine mucosa, and its sequence contains a portion of glucagon and glucagon. This drug has a strong effect on visceral blood vessels, promoting intestinal fluid secretion and inhibiting smooth muscle contraction in the digestive tract. Aviptadil acetate has been developed for the treatment of acute respiratory distress syndrome and idiopathic pulmonary fibrosis, showing good efficacy and minimal side effects. In addition, it has been used in the treatment research of diseases such as pulmonary fibrosis, pulmonary arterial hypertension (PAH), and respiratory failure caused by .

Application&Function

Aviptadil acetate is a linear peptide containing 28 amino acids and has multiple pharmacological effects.
Vasoactive intestinal peptide (VIP), also known as Aviptadir acetate, is a linear peptide containing 28 amino acids that has several main pharmacological effects:
Vasodilation and hypotension: Aviptadil acetate can dilate blood vessels and lower blood pressure. It starts from the hepatic artery and has a strong ability to act on visceral blood vessels, but has no effect on the femoral artery.
Intestinal fluid secretion promotion: Aviptadil acetate has a strong promoting effect on intestinal fluid secretion.
Pancreatic and gastric juice secretion effects: Although the promotion effect on pancreatic secretion is weak, it can inhibit the secretion of gastric juice.
Inhibition of smooth muscle contraction in the digestive tract: Aviptadil acetate can also have an inhibitory effect on the contraction of smooth muscle in the digestive tract.
Anti inflammatory and cell protective effects: Aviptadil acetate also exhibits anti-inflammatory and cell protective effects. It can inhibit the basal proliferation of pulmonary artery smooth muscle cells and the mobilization of free calcium concentration in these cells. In addition, it can reduce CSE induced cell death and decrease LPS induced MMP-9 activity and expression.

Specification